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We have reported that cyclophosphamide (a nitrogen mustard) functions as immunological inhibitor in the guinea pig (1) (2) (3) . Appropriately timed and in a sufficient amount, cyclophosphamide prevents the primary antibody response to a protein antigen, and guinea pigs so prepared show immunological unresponsiveness to that protein, but not to unrelated antigens (drug-induced specific immunological tolerance). Further, Salvin has shown that guinea pigs made tolerant with cyclophosphainide are relatively incapable of acquiring delayed hypersensitivity, of the Jones-Mote type, to that same protein (4, 5) . Methotrexate also blocks the acquisition of delayed hypersensitivity, as well as the primary antibody response, to specific protein in the guinea pig (6).
The effect of cancer chemotherapeutic drugs on delayed allergy to simple chemicals has been studied in the guinea pig (7-9). Both cyclophosphamide and methotrexate block the acquisition of allergic contact dermatitis during the period of their administration; however, the drugtreated guinea pigs become permanently sensitive as soon as drug is stopped. Treatment with methotrexate or cyclophosphamide of guinea pigs already sensitive to DNCB does not abolish their hypersensitivity (7, 9).
In past studies it seemed that the ultimate DNCB challenge reactions of cyclophosphamidesuppressed guinea pigs might be even more intense and prolonged than those of control animals. This would certainly have been a para- and injected intraperitoneally daily for 5 days. On day 5, the guinea pigs were topically sensitized by the application of 0.5 mg DNCB in acetone to a pre-sacral area 2 cm in diameter. Ten days later (day 15) the guinea pigs were challenged with DNCB/acetone solutions of the following concentrations: 0.1%, 0.05%, 0.025%, and 0.0125%; 0.02 ml of these solutions, as well as 0.02 ml of a 0.1% croton oil/acetone solution, were pipetted onto 1 cm diameter pm-marked areas on the flanks of the guinea pigs. Reactions were read at 24, 48, and 72 hours. Sensitization and challenge sites had been Zip® wax-epilated several days prior to DNCB application. The cyclophosphamide-treated guinea pigs developed a transient leukopenia, but by the time of challenge their white blood counts had returned to normal.
The experimental design is outlined in Figure 1 , and the results are set down in Table I . The methods are similar to those of previous studies (10, 11) .
RESULTS
The DNCB challenge responses of the experimental group were qualitatively more intense and more prolonged (Table I ). There were no significant differences between the croton oil reactions of the two groups. We have obtained comparable results using paraphenylenediamine as sensitizer.
CONCLUSIONS
Generally, whole body x-ray and the cancer chemotherapeutic drugs suppress primary antibody formation and the acquisition of delayed hypersensitivity (12) (13) (14) . There is considerable species variation in the inhibitory effect of the t Supplied through the kindness of Dr. Max Ordinarily, cyclophosphamide inhibits the acquisition of delayed hypersensitivity in the guinea pig. However, we have now demonstrated that cyclophosphoamide may also perform as immunological adjuvant and produce precisely the reverse effect: exaggerated hypersensitivity. It seems likely that whole body x-ray as well as other of the immunosuppressive cancer chemotherapeutic drugs can be so manipulated as to enhance the acquisition of allergic contact dermatitis (27) . The mechanism by which cyclophosphamide enhances the acquisition of DNCB contact dermatitis is unclear. Trophic factors have been described for lymphoid tissue (28) . It may be that these factors are immunotrophic as well as lymphotrophic, and thereby lead to an inimunologically more efficient processing of simple chemical and other allergens. Certainly, the rapid and seemingly complete restoration of lymphoid tissue after near-complete destruction by cyclophosphamide (or x-ray) is impressive and implies a sensitive and dynamic homeostasis of lymphoid tissue. It would be surprising if these regulatory mechanisms did not importantly direct the immunological performance of lymphoid tissue. On this basis we would predict that diverse treatments having the common result of depression followed by regeneration of lymphoid tissue could enhance the hypersensitivity response. Such potential immunological adjuvants would include heterologous antilymphocyte sera, glucosteroids and certain viruses, as well as whole body x-ray and many of the cancer chemotherapeutic drugs. * Animals "I" to "XII" received cyclophosphamide; animals "XIII" to "XXIV" were controls.
Challenge Reactions
Reactions were read at 24,48, and 72 hours and graded according to the following criteria: Negativeno definite reaction; trace-less than 25% erythema; 1+-25% to 80% erythema; 2+-greater than 80% erythema and/or edema; 3+-exudation. Meaningful readings on the rapidly evolving croton oil reactions could be made only at 24 hours.
SIJMMARY
Guinea pigs received a S day course of cyclophosphamide, and on day 5 were topically sensitized to dinitrochlorobenzene (DNCB). The DNCB challenge reactions of these guinea pigs were exaggerated and prolonged. This represents a paradoxical effect, since cyclophosphamide is a well-established immunological inhibitor in the guinea pig. 
